Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Debt / NOTE 11/0
-
Number of holders
-
38
-
Total 13F principal, excl. options
-
515,788,680
-
Principal change
-
+515,788,680
-
Total reported value, excl. options
-
$486,897,748
-
Value change
-
+$486,895,635
-
Number of buys
-
38
-
Price
-
$0.9188
Significant Holders of NOVOCURE LTD - NOTE 11/0 as of Q4 2021
39 filings reported holding 67011XAB9 - NOVOCURE LTD - NOTE 11/0 as of Q4 2021.
NOVOCURE LTD - NOTE 11/0 has 38 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $515,788,680 of principal
.
Largest 10 bondholders include Allianz Asset Management GmbH ($81,640,000 of principal), WOLVERINE ASSET MANAGEMENT LLC ($80,367,000 of principal), CITADEL ADVISORS LLC ($76,750,000 of principal), Linden Advisors LP ($63,485,000 of principal), DeepCurrents Investment Group LLC ($46,391,000 of principal), Verition Fund Management LLC ($33,485,000 of principal), BANK OF AMERICA CORP /DE/ ($18,506,000 of principal), STATE STREET CORP ($17,600,000 of principal), CALAMOS ADVISORS LLC ($17,283,000 of principal), and CAPSTONE INVESTMENT ADVISORS, LLC ($9,908,000 of principal).
This table shows the top 38 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.